165 related articles for article (PubMed ID: 31578574)
21. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma.
Khales SA; Mozaffari-Jovin S; Geerts D; Abbaszadegan MR
BMC Cancer; 2022 Dec; 22(1):1272. PubMed ID: 36474162
[TBL] [Abstract][Full Text] [Related]
22. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
23. Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.
Yu M; Zhang C; Li L; Dong S; Zhang N; Tong X
Oncol Rep; 2014 Jun; 31(6):2751-8. PubMed ID: 24789679
[TBL] [Abstract][Full Text] [Related]
24. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
25. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
[TBL] [Abstract][Full Text] [Related]
26. NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer.
Matsuura N; Tanaka K; Yamasaki M; Yamashita K; Saito T; Makino T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Nakagawa H; Doki Y
Cancer Med; 2021 Jun; 10(12):3986-3996. PubMed ID: 34042293
[TBL] [Abstract][Full Text] [Related]
27. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
[TBL] [Abstract][Full Text] [Related]
28. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
29. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin.
Zhu X; Shen H; Yin X; Long L; Xie C; Liu Y; Hui L; Lin X; Fang Y; Cao Y; Xu Y; Li M; Xu W; Li Y
Oncogene; 2016 Jan; 35(3):323-32. PubMed ID: 25867064
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
31. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
Zhang Z; Xiong R; Li C; Xu M; Guo M
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
Brum MCM; Dos Santos Guimaraes I; Ferreira LB; Rangel LBA; Maia RC; Nestal De Moraes G; Gimba ERP
Oncol Rep; 2021 Feb; 45(2):652-664. PubMed ID: 33416171
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
34. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
Gou W; Zhou X; Liu Z; Wang L; Shen J; Xu X; Li Z; Zhai X; Zuo D; Wu Y
Cancer Lett; 2018 May; 422():19-28. PubMed ID: 29477381
[TBL] [Abstract][Full Text] [Related]
35. FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
Zhai Y; Shan C; Zhang H; Kong P; Zhang L; Wang Y; Hu X; Cheng X
Mol Cell Biochem; 2022 Dec; 477(12):2689-2702. PubMed ID: 35606602
[TBL] [Abstract][Full Text] [Related]
36. MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE-30.
Mahmoudian RA; Bahadori B; Rad A; Abbaszadegan MR; Forghanifard MM
Mol Genet Genomic Med; 2019 Jul; 7(7):e00746. PubMed ID: 31090196
[TBL] [Abstract][Full Text] [Related]
37. DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.
Kang KA; Ryu YS; Piao MJ; Shilnikova K; Kang HK; Yi JM; Boulanger M; Paolillo R; Bossis G; Yoon SY; Kim SB; Hyun JW
Redox Biol; 2018 Jul; 17():224-235. PubMed ID: 29715584
[TBL] [Abstract][Full Text] [Related]
38. Expression of Insulin-Like Growth Factor Binding Protein-5 (
Chan D; Zhou Y; Chui CH; Lam KH; Law S; Chan AS; Li X; Lam AK; Tang JCO
Cells; 2018 Sep; 7(10):. PubMed ID: 30241323
[TBL] [Abstract][Full Text] [Related]
39. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.
Wang M; Li Y; Yang Y; Liu X; Zang M; Li Y; Yang K; Yang W; Zhang S
Mol Med Rep; 2019 Mar; 19(3):1942-1950. PubMed ID: 30592268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]